The hypothesis is presented that a human T-cell leukemia virus (HTLV) 
disease in humans. First, investigators at the U.S. National Cancer Institute [7, 8] , as well as Japanese workers [9, 10] , have demonstrated virological and antibody evidence of a human T-cell leukemia virus (HTLV) in patients with human T-cell leukemia or lymphomas and have defined its unusual epidemiological occurrence in adults, in blacks and Japanese, and geographically in southern Japan, southern U.S., and in the Caribbean islands. Antibody has been found in family contacts of cases and in healthy persons in endemic areas [8, 9] . Both the leukemia and the presence of antibody in healthy persons are limited to adults, suggesting the possibility of a sexually transmitted agent as in HSV-2. The second development is the occurrence of the acquired immunodeficiency syndrome (AIDS) in male homosexuals, hemophiliacs, heroin and other drug users (including amyl nitrate), and Haitians [11, 12] . The high-risk group is expanding to include infants and children in the families of AIDS patients, as well as recipients of their blood. Epidemiologically, this suggests the possibility of spread by sexual activity, blood and blood products, and by vertical transmission. These routes are similar to hepatitis B virus (HBV) and raise concern about the potential spread of [15] and HTLV as a possible cause proposed by Gellman and Gallo [16] at a recent meeting in New York City. HTLV apparently infects helper cells preferentially [7] . As this essay is being completed, scientific evidence supporting the possible role of HTLV in AIDS has appeared from the National Cancer Institute and other centers [17] as well as possible evidence of person-to-person [18] [19] and perinatal transmission [19] . The details of this relationship to HTLV have just been published in a series of five papers in Science [20] [21] [22] [23] [24] . [8] or a lytic response leading to AIDS. The ATL syndrome is seen primarily in adults of both sexes, in Japanese in southern Japan, and in the Caribbean islands and southern U.S. [8, 9] . AIDS has been recognized primarily in young and middle-aged adult males in the U.S., Haiti, and some foreign countries. No outbreak of the AIDS syndrome has been reported from southern Japan where up to 30 percent of healthy adults including both males and females have HTLV antibody [8, 9] although one case has recently been noted [25] . The factors that lead to a lytic or proliferative response to HTLV are unknown, as are the different geographic and ethnic differences. Certainly, behavioral and sexual practices differ, as could the portal of entry of the agent in the leukemia/lymphoma syndrome and in AIDS, or a different strain of HTLV is involved that is lytic.
The factors resulting in a direct lytic effect of HTLV-like virus in AIDS could be due to antigenic bombardment with diverse infectious agents as seen in many active urban homosexuals, to an unusual portal of entry of HTLV, or to large dosage of the virus (many and multiple partners). The trauma and bleeding associated with active anal intercourse in the passive partner could lead to viral entry into the blood stream. The occurrence of AIDS in hemophiliacs might be related to repeated administrations of Factor VIII or blood transfusions which might contain HTLV; in Haitians the factors are unclear but are probably behavioral rather than ethnic in character. The lytic effect could also be a secondary event resulting from an initial increase in suppressor and cytotoxic T-cell activity, as seen in infectious mononucleosis [1] [2] [3] [4] [5] [26] [27] and due to neo-antigens induced on T cells by HTLV, or to other agents. Whatever its genesis, the lytic effect on helper T cells impairs a key link in our cell-mediated immune system. This could lead to (1) impaired surveillance of malignant cells, (2) reactivation of latent viruses, especially herpes viruses and latent CNS viruses, (3) reactivation of certain intracellular agents (M. avium intracellulari, T. gondii) and other opportunistic infections (Pneumocystis carinii, candida, and the like), and (4) impairment of the primary immune response to these agents. This latter problem is of major importance in homosexuals who are exposed to multiple partners, multiple antigens, and multiple portals of entry. The reactivation of EBV and cytomeglovirus (CMV) is of special interest. EBV reactivation in B lymphocytes could lead to polyclonal B-cell proliferation [14] , high EBV antibody titers, and the whole cascade of EBV events as discussed below. CMV reactivation, or the lack of control of a primary infection, might be manifested as an acute CMV mononucleosis syndrome, as lymphadenitis, or, in a more chronic phase, as Kaposi's sarcoma [14] . Like T. gondii, latent viruses in the central nervous systems also might reactivate such pathogens as papova and measles viruses, leading to progressive multifocal leukoencephalopathy (PML) and subacute sclerosing panencephalitis (SSPE) . The potential spectrum of the acute and chronic consequences of AIDS is not yet fully known and as more persons with T4/T8 disturbances are followed longer, new manifestations may be recognized. The current status of HTLV in leukemia/lymphoma and in AIDS has been well summarized in a recent editorial [26] .
THE B-CELL CASCADE Re-activation of Epstein-Barr virus (EBV) present in infected B cells may occur in patients with AIDS as manifested by an increase in EBV antibody titer, by polyclonal expansion of B cells, immunoglobulin production, and by the appearance of B-cell lymphomas. The cascade of events following primary EBV infection can be of proliferative or, less commonly, of a lytic nature. These possible outcomes are presented in Fig. 3 as derived from previous work [2] [3] [4] .
The proliferative events include the transformation and "immortalization" of B lymphocytes and a polyclonal B-cell expansion. A wide spectrum of antibodies are produced by B cells, including antibodies to various EBV antigens, the heterophile antibody, and a variety of auto-antibodies [2] . The induction of new antigens on the surface of B cells by EBV evokes a vigorous T-cell response in older children and young adults that is manifested as infectious mononucleosis. These proliferative events are usually brought under control through suppressor and cytotoxic T-lymphocyte activity as well as non-specific "killer" T lymphocytes early in disease. This makes infectious mononucleosis usually a benign and self-limited disease [2, 27, 28] [29] [30] [31] . When EBV infection occurs early in infancy in Africa there may be impairment of an appropriate cytotoxic and suppressor T-cell response and an augmentation of B-cell proliferation from the polyclonal B-cell mitogenic effect of holendemic malaria [32] . This leads to a chromosomal change in the rapidly proliferating B cells, usually a translocation of a piece of chromosome 8 to chromosome 14 (14q + translocation) which renders one B cell malignant, and the monoclonal tumor known as African Burkitt lymphoma (ABL) arises from this event, with a peak around age seven to nine [33] . There is also strong virologic association of EBV to nasopharyngeal cancer manifested by high antibody titers and the presence of EBV genome in tumor cells [34] . The tumor occurs in adults with tenfold higher incidence in Chinese. High EBV antibodies also occur in 30-40 percent of Hodgkin's disease (HD) [35] [36] even prior to diagnoses [37] , but the genome has not been demonstrated in HD tissue [38] . The proliferating B cells also produce increased immunoglobulins of various types, EBV and heterophile antibodies, and a plethora of connective tissue and other autoantibodies [39] . The lytic effect may occur in the X-linked lymphoproliferative syndrome [29] and result in B-cell loss, hypo-or aggammaglobulinemia, or aplastic anemia.
PROOF OF HYPOTHESIS The role of HTLV and of other candidate agents (CMV, HBV, and so on) in the causation of AIDS can only be established, in the author's view, by prospective serological/immunological studies as proposed at a recent National Institutes of Health Workshop on the Epidemiology of AIDS [40] , or by a suitable laboratory model, if one can be found.
The advantages of prospective (cohort) serological/immunological studies are (1) the incidence of infection, disease, and death can be measured in a defined group of persons, (2) susceptibility can often be determined at the start of the study by the presence or absence of antibody or other markers, (3) the sequence and temporal relation of serologic and immunologic events can be ascertained, (4) the risk of developing a disease can be calculated in relation to seroconversion to various microbial agents as well as to other risk factors, (5) both clues to the etiology and to pathogenesis can be uncovered, (6) given a known etiologic agent the biologic spectrum of response can be measured both quantitatively in terms of severity and qualitatively in terms of the various clinical syndromes manifested, (7) the ratio of inapparent to apparent infection (subclinical:clinical) is determinable, and (8) serum, secretions, and other materials can be obtained serially, frozen away, and tested later. The possible methods of analysis include (1) analysis and testing of the entire cohort at the start, during, and at the end of a defined period, (2) analysis and follow-up of the susceptible group alone, or (3) a case/control analysis based on retrospective analysis and testing of those who developed the disease as compared to persons shown to be susceptible at the start but who did not develop the disease [46] .
In the understanding of the etiology of AIDS the most critical issue is the temporal relationship of infection by various candidate agents to the inversion of the T4/T8 ratio and of other immunologic markers (beta 2 microglobulin, alpha interferon, thymosin), and to the development of the clinical symptoms of AIDS. It must be shown that infection with the candidate agent precedes these events, and that the incidence of infection (manifested by viral isolation and/or antibody seroconversion) is significantly higher in those that develop AIDS than in those who do not. Similar epidemiological techniques have been very useful in establishing the causal role of Epstein-Barr virus (EBV) in infectious mononucleosis [40, 41] and in African Burkitt lymphoma [34] .
In the study of AIDS, I suggest selection of exposed (homosexual, intravenous drug users, hemophiliacs) and unexposed persons to the known risk factors of AIDS. At the start, one should obtain detailed questionnaire data related to various possible risk factors and appropriate specimens. Next, identify those who are "susceptible" as determined by: (1) no clinical feature of AIDS or its prodrome, (2) normal immune system (normal T4/T8 ratio and/or normal alpha thymosin or acid labile interferon), and (3) absence of antibody to HTLV and normal EBV and CMV antibody levels (if possible to test). This susceptible group should be serially followed for evidence of changes in the immune system and seroconversion or for a rise in titer to candidate agents; of greatest interest are the serologic changes that accompany or precede a detectable change in an immunologic marker, especially T4/T8 alteration. The initial screening for "susceptibility" may be expensive and timeconsuming but attention directed at this group alone, rather than the whole cohort, may save money and effort in the end. The need for inclusion of a non-exposed group in the cohort is that serologic and immunologic events unrelated to the etiology of AIDS or antibody increases may occur that play no role in the pathogenesis of AIDS. The endpoints to be determined are the occurrence of infection, of immunologic changes or other markers, and of the clinical manifestations of AIDS. The size of the cohort needed to identify the risk factors and etiologic agent(s) of AIDS is not clear. My estimate is that of 1,000 active urban homosexuals only about 50 percent or 500 would be "susceptible" (with a normal T4/T8 and alpha thymosin level) and that 10 percent of these (50) might be "infected" per year, of whom perhaps 2-10 percent (one to five persons) would develop clinical manifestations of AIDS. For comparison, a prospective study of 1,400 West Point cadets for the role of EBV in infectious mononucleosis showed 437 were susceptible at the start (lacked EBV antibody), 54 were infected during the first year, and there were 15 clinical cases of infectious mononucleosis [42] . Thus, a cohort of considerable size may be required to yield many cases of AIDS. Concentrating on a high-risk, susceptible population and a susceptible heterosexual control group would seem to be the most efficient approach. If AIDS is due to a single transmissible agent then great geographical differences might exist in these estimates, depending upon whether or not the agent has been introduced, the prevalence of infected persons in the community, and the probability of an infected person and a susceptible coming into appropriate contact. As of this writing, five prospective studies with approximately 1,000 homosexuals in each have been funded by NIH in five urban centers. Sera already collected in the hepatitis B vaccine trial in homosexuals in New York City [43] could also be tested to determine if the incidence of HTLV (or other) infection was higher in those persons later developing AIDS than in those remaining normal. Unfortunately, lymphocytes were not collected and frozen away in that study so that the relationship of infection to T4/T8 conversion can not be measured. The study of hemophiliacs who subsequently developed AIDS and of the donors to the pool of Factor VIII, as recently reported [44] [46] , hepatitis B virus and/or its associated Delta agent [50] [51] , and a human T-cell leukemia or related retrovirus [21] [22] [23] [24] . The pled. In mny view, the evidence of transmission of AIDS via blood or blood products, even though rare, gives strong support to the concept that an infectious agent in the blood can transmit AIDS even to relatively healthy recipients [43] . If the subclinical: clinical ratio of infection to disease is high, then we must be concerned about the prevalence of unrecognized infection and the duration of an unrecognized infectious state in high-risk populations. I feel that the agent responsible is probably newly introduced into the U.S. and that a HTLV-like agent is a strong candidate for causation. ADDENDUM Strong evidence implicating a HTLV-like virus, one termed HTLV-III, has been presented by Gallo 
